MEDICAMENT ANTI–VIH, POLYPEPTIDE CONSTITUANT LEDIT MEDICAMENT, GENE CODANT LE POLYPEPTIDE ET PROCEDE DE PRODUCTION DU MEDICAMENT ANTI

MEDICAMENT ANTI–VIH, POLYPEPTIDE CONSTITUANT LEDIT MEDICAMENT, GENE CODANT LE POLYPEPTIDE ET PROCEDE DE PRODUCTION DU MEDICAMENT ANTI–VIH

N° de brevet:	EP1842548 (A1)
Date de publication:	2007-10-10
Inventeur(s):	TANAKA HARUO [JP];INOKOSHI JUNJI [JP];OMURA SATOSHI [JP];
Demandeur(s):	KITASATO GAKUEN FOUNDATION [JP];
Classification:	A61K38/00;A61P31/18;C12P21/02;C12N1/15;C12N1/21;C12N15/09;C07K14/36;
N° de demande:	EP20050811568 20051130
Numéro(s) de priorité:	WO2005JP21981 20051130;JP20040346644 20041130

It is intended to provide an anti-HIV agent characterized by comprising a multimer of Actinohivin; a polypeptide which is a multimer of Actinohivin; constituting the same, DNA gene encoding the polypeptide; and a method for producing the anti-HIV agent. The present invention is aimed to provide the anti-HIV agent working by inhibiting syncytium formation and having enhanced effect.